Finance

Beta
Lists
KLRA:NASDAQ
Kailera Therapeutics Inc
$22.50
+5.29%
(+1.13) 1D
Jun 24, 12:37:12 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KLRA...
Open
$21.44
High
$22.86
Low
$21.08
Mkt. cap
2.92B
Avg. vol.
595.33K
Volume
166.53K
52-wk high
$28.23
52-wk low
$18.50
No. of employees
145
Open
$21.44
High
$22.86
Low
$21.08
Mkt. cap
2.92B
Avg. vol.
595.33K
Volume
166.53K
52-wk high
$28.23
52-wk low
$18.50
No. of employees
145
News stories
From sources across the web
About Kailera Therapeutics Inc
CEO-
Employees145
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitekailera.com
Analyst Ratings
Based on 5 analysts giving stock ratings to KLRA in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for KLRA in the last 3 months.
Highest
Current $22.50
$48.00 (+113.33%)
Average
$39.00 (+73.33%)
Lowest
$30.00 (+33.33%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Roger Song
Jefferies
Buy
Maintained
$48.00
+113.3%
05/28/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
05/27/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
05/26/2026
Umer Raffat
Evercore ISI
Buy
Initiated
-
-
05/12/2026
Hardik Parikh
J.P. Morgan
Buy
Initiated
$30.00
+33.3%
05/12/2026
Last report
May 26, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$3,650.00 / -$0.55
-664,987.46%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer